OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 75 filers reported holding OCULAR THERAPEUTIX INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,000 | +63.2% | 25,900 | +135.5% | 0.00% | +100.0% |
| Q2 2021 | $19,000 | -98.5% | 11,000 | -82.5% | 0.00% | -97.4% |
| Q4 2020 | $1,305,000 | +18542.9% | 63,034 | +489.1% | 0.04% | – |
| Q1 2020 | $7,000 | -50.0% | 10,700 | -2.7% | 0.00% | -100.0% |
| Q1 2017 | $14,000 | -6.7% | 11,000 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $15,000 | +200.0% | 10,300 | -3.7% | 0.00% | – |
| Q3 2016 | $5,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |